NCT02125344 2017-07-13A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)GBG Forschungs GmbHPhase 3 Completed961 enrolled